CX 2019 Presentations
Please note: Some presentations may not be available as permission may not have been given to publish. Sometimes this will include a debate session, during which one speaker has given permission but another speaker has denied it, resulting in the entire session not being uploaded to the website.
Peripheral Arterial Podium 1st Session - Thursday, 18th April
Venue: Lower Main Auditorium
Time: 10:30 - 12:30
Time: 10:30 - 10:38
Podium 1st: First results of the MUST trial and further updates on the use of microbubbles in thrombolysis
| Speaker: | Kak Khee Yeung, Amsterdam, Netherlands |
Time: 10:38 - 10:46
Podium 1st: Angiography alone in the lower limb: First results comparing IVUS and angiography in the leg
| Speaker: | Konstantinos Stavroulakis, Münster, Germany |
Time: 10:46 - 10:54
Podium 1st: Intravascular lithoplasty: Study status (DISRUPT PAD II and III) and lessons learnt from a real-world registry
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:06 - 11:14
Podium 1st: The case for treating aortoiliac occlusive disease with a covered device: Early experience with new balloon-expandable endoprosthesis
| Speaker: | Michele Antonello, Padua, Italy |
Time: 11:14 - 11:22
Podium 1st: DCB IDE below-the-knee six-month results with in-depth look at Rutherford 5 patients
| Speaker: | Patrick Geraghty, St. Louis, United States |
Time: 11:22 - 11:30
Podium 1st: Final results of preclinical study comparing drug delivery on 0.018" vs. 0.035" DCB platforms
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:42 - 11:50
Podium 1st: Two-year data from the MIMICS-2 study
| Speaker: | Timothy Sullivan, Minneapolis, United States |
Time: 11:50 - 11:58
Podium 1st: ZILVERPASS study - final 12-month and preliminary 24-month results
| Speaker: | Marc Bosiers, Dendermonde, Belgium |
Time: 12:06 - 12:14
Podium 1st: Multivariate analysis of 2,400 patients using a drug-eluting stent - patency data
| Speaker: | Michael Dake, Tucson, United States |
Time: 12:14 - 12:22
Podium 1st: REPLACE study - heparin-bonded ePTFE graft vs. ePTFE graft
| Speaker: | Yann Gouëffic, Nantes, France |